
Benigno D. Peczon
Dear Editor:
Please allow us to respond to the point raised by Mr. Lopez:
* Transnational corporations (TNCs) hope to control global agriculture
by inducing dependence on these through monopoly of GE seed production*.
Seed companies have indeed sought to control their product by limiting
farmers from saving seeds for future planting. In the late '90s, the
US government granted a patent to an invention that allowed GE plants
to produce sterile seeds. The technology was later used by Monsanto to
develop bio-engineered corn carrying these so-called terminator genes
for distribution and sale. But the strong backlash from the public,
including farmer and consumer groups and the science community, forced
Monsanto to drop the use of this technology.
It should be noted that TNCs, by the fact that they are
profit-oriented entities, will always seek to achieve a position where
profits can be maximized and costs minimized. All business entities,
down to the sari-sari store, strive to do the same. We, the members of
the Biotechnology Conference of the Philippines (BCP), realize and
accept this reality. However, we are also aware that biotechnology
provider opportunities for improved food security, environment and
health, and that any risks it may entail must be scientifically
identified and then managed. It is for this reason that we urge, among
other actions, increased government and private sector support for
biotechnology research by Filipino scientists, since ownership and
control of technologies by Filipinos provide better access for
Filipinos to such technologies. We might get our cue from China. China
has adopted full government support for biotechnology precisely to
prevent control of GE technology by TNCs. It invested massively in
genetically modified organism (GMO) R&D. Today, Chinese farmers have a
choice of buying seeds from TNCs or from their own seed companies.
* TNCs use Third World nations as guinea pigs to test the viability of
GE crops. They first targeted Europe and the US as the prime GE
market, but found strong resistance from their consumers who are
highly informed.*
The first field trials of transgenic crops were performed in the USA
and France in 1986. Since then, more than 7,000 field trials have been
conducted on more than 30,000 individual sites in about 40 countries,
initially in North America and the European Union, but with Latin
America and Asia making headway. The US approved commercial production
of GE tomatoes on Oct. 19, 1992. Commercial production of Bt corn was
approved in that country on May 17, 1995. As of April 15, 2001, the US
Department of Agriculture's Animal and Plant Health Inspections
Service has approved 55 petitions for crops to be commercially
produced after these went through stringent testing. In the year 2000,
20% of the corn grown in the US was genetically modified. It is
therefore inaccurate to claim that Third World countries are guinea
pigs for GMOs. If there are people to be labeled as "guinea pigs" for
GMOs, the facts indicate that these are Americans. It is likewise
misleading to claim that there is strong resistance against GMOs among
Americans. Market research has found that the average US consumer is
not bothered with the issue of GE products for food so long as these
pass stringent government regulatory standards.
As far as Europe is concerned, it should be pointed out that although
the most active resistance from GMOs can be observed among Europeans,
dynamic and fast-growing firms which are engaged in research and the
field testing of various GMOs are also located in the continent.
* Pro-GE advocates mostly argue in terms of economics - maximizing
yield and minimizing cost - sacrificing health and environment
considerations.*
On the contrary, advocates of biotechnology believe that the benefits
from this new science transcend mere economics. Many in fact argue
solely in terms of health and environment considerations. Health
benefits include the development of more nutritional food (e.g., crops
carrying additional vitamins), fruits containing vaccines and the
production of more effective, specialized medicines. Environmental
benefits may accrue indirectly, for example, through the introduction
of pest-resistant crops that allow farmers to use smaller quantities
of pesticides, or directly, for example, through the use of
bio-engineered bacteria for decontamination of industrial and
household wastes.
* TNC modus operandi in the Philippines is to get the support of NGOs
and farmer associations as the backbone of their advocacy campaign.
Another style is to put up their own association or NGOs. Some pro-GE
groups retaliate by labeling anti-GE farm associations and NGOs as
"communists," or alleging that they are funded by environment and
anti-GE groups in Europe*.
We would like to believe in the good faith and sincerity of every
individual or group advocating for particular causes and concerns. As
a member of the larger community, each and every one of us endeavors
to build a better society for ourselves and for our children. We find
the use of labels unproductive, as these tend to reduce issues into
non-arguments and debase rational thinking into knee-jerk reactions.
More often than not, labels polarize protagonists as helpless captives
of extreme positions. What we should encourage are consensus building,
dialogue and open communication with all stakeholders including those
with opposing views. After all, it is best to work for open covenants
openly arrived at.
We at the Biotechnology Conference of the Philippines (BCP) believe
that the potential of biotechnology to fully contribute to national
development efforts can only be achieved through "a dynamic and
unfettered and yet objective exchange of information and ideals from
within and among the State, science community and the general public"
(BCP Statement of Principles). We ask for enlightened support for this
worthwhile science and technology, one that is founded on and spurred
by the pursuit of truth and the public good.
- BENIGNO D. PECZON, Ph.D., Head Convenor, BCP,
c/o Biotechnology Assoc of the Philippines, 66 United St., Mandaluyong
City
** NOTICE: In accordance with Title 17 U.S.C. Section 107, this material is distributed for research and educational purposes only. ** |
|
|
Last Updated on 7/2/01 Email: information@biotech-info.net |
|